Literature DB >> 10866369

Hepatitis C viral IRES inhibition by phenazine and phenazine-like molecules.

W Wang1, P Préville, N Morin, S Mounir, W Cai, M A Siddiqui.   

Abstract

An in vitro assay based on the expression of Fluci reporter gene under the translational control of HCV IRES was used to evaluate and screen compound libraries. A structure-activity relationship study on a phenazine hit was conducted. Our data suggest that an intact phenazine or phenazine-like core with two distal polar substitutions is crucial for potency.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10866369     DOI: 10.1016/s0960-894x(00)00217-1

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  12 in total

1.  Inhibitor RNA blocks the protein translation mediated by hepatitis C virus internal ribosome entry site in vivo.

Authors:  Xue-Song Liang; Jian-Qi Lian; Yong-Xing Zhou; Mo-Bin Wan
Journal:  World J Gastroenterol       Date:  2004-03-01       Impact factor: 5.742

Review 2.  Synthetic small-molecule RNA ligands: future prospects as therapeutic agents.

Authors:  A Di Giorgio; M Duca
Journal:  Medchemcomm       Date:  2019-04-30       Impact factor: 3.597

3.  The Novel Amidase PcnH Initiates the Degradation of Phenazine-1-Carboxamide in Sphingomonas histidinilytica DS-9.

Authors:  Yijun Ren; Mingliang Zhang; Siyuan Gao; Qian Zhu; Zhijian Ke; Wankui Jiang; Jiguo Qiu; Qing Hong
Journal:  Appl Environ Microbiol       Date:  2022-05-17       Impact factor: 5.005

Review 4.  Bioprospecting Sponge-Associated Microbes for Antimicrobial Compounds.

Authors:  Anak Agung Gede Indraningrat; Hauke Smidt; Detmer Sipkema
Journal:  Mar Drugs       Date:  2016-05-02       Impact factor: 5.118

5.  HCV genetics and genotypes dictate future antiviral strategies.

Authors:  Louis Papageorgiou; Chrisanthy Vlachakis; Konstantina Dragoumani; Sofia Raftopoulou; Dimitrios Brouzas; Nicolas C Nicolaides; George P Chrousos; Evangelia Charmandari; Vasileios Megalooikonomou; Dimitrios Vlachakis
Journal:  J Mol Biochem       Date:  2017-12-10

Review 6.  Hepatitis C virus translation inhibitors targeting the internal ribosomal entry site.

Authors:  Sergey M Dibrov; Jerod Parsons; Maia Carnevali; Shu Zhou; Kevin D Rynearson; Kejia Ding; Emily Garcia Sega; Nicholas D Brunn; Mark A Boerneke; Maria P Castaldi; Thomas Hermann
Journal:  J Med Chem       Date:  2013-11-05       Impact factor: 7.446

7.  N6-methyladenosine modification of HCV RNA genome regulates cap-independent IRES-mediated translation via YTHDC2 recognition.

Authors:  Geon-Woo Kim; Aleem Siddiqui
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-09       Impact factor: 12.779

Review 8.  A review on lawsone-based benzo[a]phenazin-5-ol: synthetic approaches and reactions.

Authors:  Abolfazl Olyaei; Mahdieh Sadeghpour
Journal:  RSC Adv       Date:  2022-05-09       Impact factor: 4.036

9.  HCV IRES-mediated core expression in zebrafish.

Authors:  Ye Zhao; Wei Qin; Jing-Pu Zhang; Zhan-Ying Hu; Jun-Wei Tong; Cun-Bao Ding; Zong-Gen Peng; Li-Xun Zhao; Dan-Qing Song; Jian-Dong Jiang
Journal:  PLoS One       Date:  2013-03-01       Impact factor: 3.240

10.  Blood shizonticidal activities of phenazines and naphthoquinoidal compounds against Plasmodium falciparum in vitro and in mice malaria studies.

Authors:  Nicolli Bellotti de Souza; Isabel M de Andrade; Paula F Carneiro; Guilherme A M Jardim; Isadora M M de Melo; Eufrânio N da Silva Júnior; Antoniana Ursine Krettli
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-08-05       Impact factor: 2.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.